Immatics Future Growth
Future criteria checks 0/6
Immatics's revenue and earnings are forecast to decline at 5.1% and 22.8% per annum respectively while EPS is expected to decline by 17.2% per annum.
Key information
-22.8%
Earnings growth rate
-17.2%
EPS growth rate
Biotechs earnings growth | 42.4% |
Revenue growth rate | -5.1% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 22 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 50 | -160 | -183 | N/A | 5 |
12/31/2025 | 61 | -137 | -144 | N/A | 7 |
12/31/2024 | 116 | -63 | -134 | N/A | 6 |
9/30/2024 | 116 | -56 | -45 | -20 | N/A |
6/30/2024 | 71 | -74 | -45 | -17 | N/A |
3/31/2024 | 74 | -80 | -26 | 9 | N/A |
12/31/2023 | 54 | -97 | -13 | 18 | N/A |
9/30/2023 | 76 | -84 | -117 | -92 | N/A |
6/30/2023 | 85 | -79 | -113 | -94 | N/A |
3/31/2023 | 80 | -68 | -40 | -31 | N/A |
12/31/2022 | 173 | 38 | 94 | 100 | N/A |
9/30/2022 | 151 | 34 | 97 | 102 | N/A |
6/30/2022 | 142 | 28 | 113 | 119 | N/A |
3/31/2022 | 130 | 15 | 38 | 44 | N/A |
12/31/2021 | 35 | -93 | -90 | -85 | N/A |
9/30/2021 | 28 | -95 | -86 | -81 | N/A |
6/30/2021 | 30 | -231 | -133 | -127 | N/A |
3/31/2021 | 32 | -226 | -97 | -91 | N/A |
12/31/2020 | 31 | -211 | -88 | -81 | N/A |
9/30/2020 | 26 | -208 | -38 | -31 | N/A |
6/30/2020 | 23 | -49 | 75 | 81 | N/A |
3/31/2020 | 22 | -34 | 55 | 60 | N/A |
12/31/2019 | 18 | -32 | 69 | 71 | N/A |
12/31/2018 | 4 | -31 | 20 | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4A3 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4A3 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4A3 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4A3's revenue is expected to decline over the next 3 years (-5.1% per year).
High Growth Revenue: 4A3's revenue is forecast to decline over the next 3 years (-5.1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4A3's Return on Equity is forecast to be high in 3 years time